Search Results - Philipp Oster

Immunogenicity and safety of MenACWY-TT, a quadrivalent meningococcal tetanus toxoid conjugate vaccine recently licensed in the United States for individuals ≥2 years of age by Gary S. Marshall, Stephen I. Pelton, Corwin A. Robertson, Philipp Oster

Connect to this object online.

Immune persistence and booster response of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) 5 years after primary vaccination of adults at ≥56 years of age by Corwin A. Robertson, Jeffry Jacqmein, Alexandre Selmani, Katherine Galarza, Philipp Oster

Connect to this object online.

Invasive meningococcal disease in older adults in North America and Europe: is this the time for action? A review of the literature by Sandra Guedes, Isabelle Bertrand-Gerentes, Keith Evans, Florence Coste, Philipp Oster

Connect to this object online.

Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) administered as a booster to adults aged ≥59 years: A phase III randomized study by Corwin A. Robertson, Jeffry Jacqmein, Alexandre Selmani, Katherine Galarza, Philipp Oster

Connect to this object online.

Safety and immunogenicity of meningococcal (Groups A and C) polysaccharide vaccine in children 2 to 6 y of age in China: a randomized, active-controlled, non-inferiority study by Feng-Cai Zhu, Yue-Mei Hu, Ya-Nan Li, Jean-Denis Shu, Philipp Oster

Connect to this object online.

Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine (MenACYW-TT) versus a quadrivalent or monovalent C... by Markus Knuf, Mika Rämet, Nina Breinholt Stærke, Isabelle Bertrand-Gerentes, Yaël Thollot, Siham B'Chir, Habiba Arroum, Philipp Oster

Connect to this object online.